HYGELIX
Live / Registered — Registered (as of 29 Apr 2025)
What this means for you
Registered since 29 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98189367
- Registration number
- 7773458
- Mark type
- Stylized text
- Filed
- 20 Sept 2023
- Published for opposition
- 11 Mar 2025
- Registered
- 29 Apr 2025
- Attorney of record
- Mary L. Grieco
Goods and services
- Class 010 — Medical apparatus: Medical devices used in ocular surgery; surgical instruments; surgical implantation devices used in corneal transplant surgery; hydrogel film in the nature of ocular implants made of artificial materials combined with human tissue for medical purposes, namely, ocular surgery, intra-ocular surgery, and corneal transplants
- Class 044 — Medical, beauty and agricultural services: Medical services; ocular surgical services; medical treatment services; surgical treatment services, namely, corneal transplant and repair procedures; surgical procedures in the nature of ocular surgery; treatment of disease, namely, treatment of eye diseases and conditions
Owner
- The University of Melbourne, Parkville Victoria, AU
- The University of Melbourne, Parkville Victoria, AU
- The University of Melbourne, Parkville Victoria, AU
Prosecution history
- 29 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Mar 2025 — PUBLISHED FOR OPPOSITION
- 05 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Feb 2025 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 12 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Oct 2024 — ASSIGNED TO LIE
- 18 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Apr 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 11 Apr 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 23 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Jan 2024 — NON-FINAL ACTION E-MAILED